NCT02886988View on ClinicalTrials.gov

Early Postoperative Prevention and Treatment of Median Sternotomy Scars With Botulinum Toxin Type A Injection

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

December 28, 2017

Study Completion Date

January 22, 2018

Conditions
Scar
Interventions
DRUG

Botulinum toxin type A

50 units of botulinum toxin diluted in 1 ml of normal saline will be administered. 0.1mlof BTA will be injected with a 30G needle.

DRUG

normal saline

0.1mlof normal saline will be injected with a 30G needle.

Trial Locations (1)

710032

Xijing Hospital, Xi'an

All Listed Sponsors
lead

Xijing Hospital

OTHER

NCT02886988 - Early Postoperative Prevention and Treatment of Median Sternotomy Scars With Botulinum Toxin Type A Injection | Biotech Hunter | Biotech Hunter